Cullinan Therapeutics: Casting A Wide Net With Their Pipeline

Cullinan Therapeutics (NASDAQ: CGEM ) is a multifocal biotech working on a variety of different programs in precision medicine and immunotherapy. For the past six months, they've taken a serious beating in terms of market sentiment, falling around 60% from its high inI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech companies. It is my passion to educate everyone possible on the science behind the businesses that we invest in, and it's my mission to help you do yo ...